|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 14/71 | (2006.01) |
| C07K 16/46 | (2006.01) | ||
| A61K 38/17 | (2006.01) | ||
| A61P 9/12 | (2006.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 13/12 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3628049 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18794202.4 |
| Date of filing the European patent application | 2018-05-03 | |
| (97) | Date of publication of the European application | 2020-04-01 |
| (45) | Date of publication and mention of the grant of the patent | 2023-05-10 |
| (46) | Date of publication of the claims translation | 2023-08-25 |
| (86) | Number | PCT/US2018/030816 |
| Date | 2018-05-03 |
| (87) | Number | WO 2018/204594 |
| Date | 2018-11-08 |
| (30) | Number | Date | Country code |
| 201762501229 P | 2017-05-04 | US | |
| 201762510422 P | 2017-05-24 | US | |
| 201762578674 P | 2017-10-30 | US |
| (72) |
KUMAR, Ravindra , US
SAKO, Dianne S. , US
|
| (73) |
Acceleron Pharma Inc. ,
128 Sidney Street, Cambridge, MA 02139,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | TGF-beta II tipo receptoriaus sulieti baltymai ir jų panaudojimo būdai |
| TGF-BETA RECEPTOR TYPE II FUSION PROTEINS AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-04-09 | 8 | 185.00 EUR |
| 2026-05-03 |